ASX Equity Snapshot
ALA Weekly Equity Report
Arovella Therapeutics Limited
What the company does
Arovella Therapeutics Limited, a biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally. It product pipeline includes ALA-101 CD19, which is a next-generation off-the-shelf CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukaemias; ALA-105 CLDN18.2 for targeting Claudin 18.2, which is expressed in gastric cancer, gastroesophageal junction cancer, pancreatic cancer, and lung and ovarian cancer; and IL-12-TM for treating solid tumors. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was …
What the weekly tape is saying
ALA closed the latest completed week at 0.07 AUD. The 4-week return is -10.7% and the 12-week return is -5.6%. Trend Signal is inactive, Market Dynamics is -0.76. Setup signature: Risk-first tape with a 14/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 0.08 AUD
- Vs Trend Line
- -16.4%
- Fair Value
- 0.11 AUD
- Vs Fair Value
- -39.6%
- 52W High
- 0.12 AUD
- 52W Low
- 0.07 AUD
- Drawdown
- -46.4%
- Range Position
- 3.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 5
- 52W Active Breadth
- 9.6%
- Sector Scope
- AU Healthcare
- Sector Rank
- 85 of 146
- Sector Percentile
- 42.1%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AU Healthcare
- Tracked Peers
- 100
- 4W Rank
- 67 of 100
- Avg 1W
- -1.4%
- Avg 4W
- -3.6%
- Trend Breadth
- 15.0%
- Positive MD
- 39.0%
AU Biotechnology
- Tracked Peers
- 47
- 4W Rank
- 28 of 47
- Avg 1W
- -0.1%
- Avg 4W
- -5.8%
- Trend Breadth
- 10.6%
- Positive RS
- 21.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.76
- 4W MD Change
- -94.9%
- Relative Strength
- -22.61
- 4W RS Change
- -83.6%
- Expectation
- Negative
- Probability
- 38.65%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 3.6M
- 13W Average
- 4.7M
- 52W Average
- 5.9M
- Vs 13W
- 0.8x
- Vs 52W
- 0.6x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 10.7%
- 52W Volatility
- 9.2%
- Upside Weeks
- 17
- Downside Weeks
- 31
- Downside Breadth
- 59.6%
- Avg Gain / Loss
- 9.7% / -5.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- ASX
- Country
- AU
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- AUD
- Market Cap
- 85.8M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.07 AUD | -2.9% | 0.08 AUD | 0.11 AUD | -0.76 | -22.61 | 3.6M | Off |
| 5 Jun 2026 | 0.07 AUD | -2.8% | 0.08 AUD | 0.11 AUD | -0.75 | -18.83 | 3.2M | Off |
| 29 May 2026 | 0.07 AUD | 1.4% | 0.08 AUD | 0.11 AUD | -0.55 | -17.67 | 4.7M | Off |
| 22 May 2026 | 0.07 AUD | -6.7% | 0.08 AUD | 0.11 AUD | -0.43 | -18.27 | 4.6M | Off |
| 15 May 2026 | 0.07 AUD | -1.3% | 0.08 AUD | 0.11 AUD | -0.39 | -12.31 | 2.1M | Off |
| 8 May 2026 | 0.08 AUD | -2.6% | 0.08 AUD | 0.11 AUD | -0.25 | -12.51 | 16.0M | Off |
| 1 May 2026 | 0.08 AUD | 1.3% | 0.08 AUD | 0.11 AUD | -0.12 | -10.30 | 4.8M | Off |
| 24 Apr 2026 | 0.08 AUD | -4.9% | 0.08 AUD | 0.11 AUD | -0.34 | -12.32 | 1.5M | Off |
| 17 Apr 2026 | 0.08 AUD | -12.9% | 0.09 AUD | 0.11 AUD | -0.42 | -10.05 | 6.2M | Off |
| 10 Apr 2026 | 0.09 AUD | 34.8% | 0.09 AUD | 0.11 AUD | -0.58 | 2.94 | 6.0M | Off |
| 3 Apr 2026 | 0.07 AUD | -1.4% | 0.09 AUD | 0.11 AUD | -0.88 | -20.29 | 2.5M | Off |
| 27 Mar 2026 | 0.07 AUD | -1.4% | 0.09 AUD | 0.11 AUD | -0.69 | -18.84 | 1.7M | Off |
| 20 Mar 2026 | 0.07 AUD | -4.1% | 0.09 AUD | 0.11 AUD | -0.38 | -17.21 | 4.4M | Off |
| 13 Mar 2026 | 0.07 AUD | -3.9% | 0.09 AUD | 0.11 AUD | 0.05 | -16.18 | 2.7M | Off |